Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

UroGen Pharma to Report Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 16, 2023


UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report fourth quarter and full-year 2022 financial results on Thursday, March 16, 2023, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.

A live public webcast of the earnings conference call can be accessed on UroGen's Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGeltm reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's first commercial product Jelmyto® (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.


These press releases may also interest you

at 16:00
Mobile Community Health Leadership Awards Honors AltaPointe Health Recreational Therapist Megan James
If you follow the sounds of joy and laughter echoing through BayPointe or EastPointe Hospital, you're likely to...

at 15:33
Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive Effect Protecting DNA From Radiation Exposure
Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR,...

at 11:28
Public advisory - Unauthorized amoxicillin capsules seized from Green Fresh Supermarket in Ottawa, ON, may pose serious health risks
SummaryProduct: Unauthorized amoxicillin capsulesIssue: Health products ? Unauthorized product, Product safetyWhat to do: Prescription drugs can only be legally sold to consumers in Canada with a prescription. Buy your prescription drugs only from...

at 10:25
empty tomb, inc. Mission Match Seeks Churches to Use Their Distribution & Frontline Networks to Keep 1 Million Children from Dying of Treatable Causes
Over 1 million children under the age of 5 are expected to die from treatable causes in 2023. empty tomb®, inc. Mission Match® is a tool to help churches in the U.S. use their own distribution networks to help these children in Jesus' name. Churches...

at 10:15
Evidence Prime Wins Main Prize for the Best Technological Solution in "The Eagle of Innovation" Competition organized by the editors of "Rzeczpospolita" daily in Poland
The price has been awarded to...

at 10:00
Senior Care Franchise Right at Home Targets Baton Rouge Expansion, Looking to Meet with Qualified Prospective Franchisees Wanting to Make a Difference in Their Community
Right at Home, the 700-plus location in-home care concept helping seniors and adults with disabilities live comfortably at home, is looking to expand in Baton Rouge, Louisiana. The opportunity gives local entrepreneurs a chance to make a difference...

More news about Health...


News published on and distributed by: